eXoZymes Inc. - Common Stock (NQ:EXOZ)
5.850
+0.090
(+1.56%)
Streaming Delayed Price
Updated: 9:37 AM EDT, Aug 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 3,755 |
| Open | 6.000 |
| Bid (Size) | 5.760 (500) |
| Ask (Size) | 6.200 (400) |
| Prev. Close | 5.760 |
| Today's Range | 5.850 - 6.000 |
| 52wk Range | 4.350 - 18.40 |
| Shares Outstanding | 8,387,250 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
eXoZymes Provides Fourth Quarter and Full Year 2025 Update
March 31, 2026
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today
November 13, 2025
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 31, 2025
12 Health Care Stocks Moving In Friday's After-Market Session ↗
October 24, 2025
Frequently Asked Questions
Is eXoZymes Inc. - Common Stock publicly traded?
Yes, eXoZymes Inc. - Common Stock is publicly traded.
What exchange does eXoZymes Inc. - Common Stock trade on?
eXoZymes Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for eXoZymes Inc. - Common Stock?
The ticker symbol for eXoZymes Inc. - Common Stock is EXOZ on the Nasdaq Stock Market
What is the current price of eXoZymes Inc. - Common Stock?
The current price of eXoZymes Inc. - Common Stock is 5.850
When was eXoZymes Inc. - Common Stock last traded?
The last trade of eXoZymes Inc. - Common Stock was at 08/13/26 09:37 AM ET
What is the market capitalization of eXoZymes Inc. - Common Stock?
The market capitalization of eXoZymes Inc. - Common Stock is 49.07M
How many shares of eXoZymes Inc. - Common Stock are outstanding?
eXoZymes Inc. - Common Stock has 49M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.